Zobrazeno 1 - 10
of 39
pro vyhledávání: '"S Belda Rustarazo"'
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Palmoplantar pustulosis (PPP) is a chronic disorder marked by the appearance of recurrent eruptions of fluid filled pustules or blisters on the hands and feet. Its aetiology is unknown and its relationship with psoriasis con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68ebdd7744a86cdb257321b60e835886
https://doi.org/10.1136/ejhpharm-2020-eahpconf.335
https://doi.org/10.1136/ejhpharm-2020-eahpconf.335
Autor:
M Galván-Banqueri, S Belda Rustarazo, S Sánchez Fidalgo, López-Malo, Santos-Rubio, A Tristancho-Pérez
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Taking multiple drugs with anticholinergic risk (AR) can adversely impact cognition and function. There are scales that rank the anticholinergic activity by the mean of the anticholinergic burden (AB) of the treatment, which is the sum of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3533a429875babe7c9971257a0e3f586
https://doi.org/10.1136/ejhpharm-2019-eahpconf.590
https://doi.org/10.1136/ejhpharm-2019-eahpconf.590
Publikováno v:
Eur J Hosp Pharm
Background Social sanitary centres (SSC) are resources that coordinate healthcare and psychosocial care to groups of dependent patients such as elderly people, patients with mental disorders or with intellectual disabilities. Purpose To describe the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35e6020a98b5ec26acc61ce6a837f09a
https://europepmc.org/articles/PMC7535256/
https://europepmc.org/articles/PMC7535256/
Autor:
R Morón-Romero, S Ruiz-Fuentes, C García-Fernandez, S. Belda-Rustarazo, C Gómez-Peña, P Gómez-Nieto
Publikováno v:
Eur J Hosp Pharm
Background The prescriptions of biologics are increasing as new indications and drugs are authorised. Since biosimilar drugs were introduced in the pharmaceutical market, they have become an alternative to continuing with the demand at competitive co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09bb1fd73e7a5ef79e21479009ea8609
https://europepmc.org/articles/PMC7535604/
https://europepmc.org/articles/PMC7535604/
4CPS-083 Evaluation of cardiovascular risk in patients on darunavir/cobicistat monotherapy treatment
Autor:
A Rodriguez Delgado, Pilar Moreno, S Belda Rustarazo, M Valle Corpas, P Nieto Gómez, I Casas Hidalgo
Publikováno v:
Eur J Hosp Pharm
Background Some of the most common adverse effects of protease inhibitors in treatment of HIV are dislypidaemia, diabetes and other metabolic disorders. These adverse effects should be recognised by health professionals so that they can perform an in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54656b90b1c6a3547f37da7a5b55c762
https://doi.org/10.1136/ejhpharm-2018-eahpconf.174
https://doi.org/10.1136/ejhpharm-2018-eahpconf.174
Autor:
S. Belda-Rustarazo, Antonio Salmerón-García, Julio Gálvez, José Cabeza-Barrera, Lorena González-García, J. Cantero-Hinojosa
Publikováno v:
International Journal of Clinical Practice. 69:1268-1274
SummaryIntroduction Medication errors are frequent at care transition points and can have serious repercussions. Study objectives were to examine the frequency/type of reconciliation errors at hospital admission and discharge and to report on the dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c470765e4ddc44903cb95146d9e6fa
https://doi.org/10.1111/ijcp.12701
https://doi.org/10.1111/ijcp.12701
Autor:
A Rodriguez Delgado, S Belda Rustarazo, C García Fernández, Mdc Gonzalez Medina, P Nieto Gómez, I Casas Hidalgo, C Gómez Peña
Publikováno v:
Other hospital pharmacy topics.
Background In different clinical studies, the use of botulinum toxin has shown a reduction in health spending, reducing the number of drugs used for patients and decreasing the number of doctor visits and the frequency of episodes. Purpose To analyse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57a470d2a393208a2453e561621f3a39
https://doi.org/10.1136/ejhpharm-2017-000640.420
https://doi.org/10.1136/ejhpharm-2017-000640.420
Publikováno v:
Clinical pharmacy.
Background Worldwide, prostate cancer is the second most commonly diagnosed cancer in men. In Europe and Spain, for many years it was the number one cancer diagnosis (436 500 in Europe in 2012 and 32 641 in Spain in 2014). 1 The use of oral therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaf1bc32d02937dc3c0b8442edec129c
https://doi.org/10.1136/ejhpharm-2017-000640.13
https://doi.org/10.1136/ejhpharm-2017-000640.13
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Journal of Hospital Pharmacy. 20:129-131
We report six cases of hyponatraemia secondary to heart failure and cirrhosis that were corrected after oral administration of crystallised urea (30 g/day in all patients). A marked clinical improvement was observed after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa4093d91996192313480a79ac97886d
https://doi.org/10.1136/ejhpharm-2012-000170
https://doi.org/10.1136/ejhpharm-2012-000170